Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial) (NutriPhyT)

August 7, 2025 updated by: HEIDEGGER CP

Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients: a Randomized Controlled Study (NutriPhyT Trial)

Due to medical advances and quality of care, mortality in adult intensive care units (ICUs) has decreased significantly in recent years, leading to a significant increase in the number of patients with high rehabilitation needs on discharge from the ICU.

A specific management by a multidisciplinary team has been set up since 2017 at the Geneva-ICU for long-stay patients (hospitalised ≥ 7 days).

This study aim to assess whether an optimization of the nutritional therapy coupled with an early mobility during and after the ICU stay allows an improvement in the muscle function at hospital discharge compared to patients receiving the standard care.

Study Overview

Detailed Description

Due to medical advances and quality of care, mortality in adult intensive care units (ICUs) has decreased significantly in recent years, leading to a significant increase in the number of patients with high rehabilitation needs on discharge from the ICU. Indeed, these patients are at high risk of complications related to their ICU stay (cognitive impairment, ICU acquired weakness, diaphragm dysfunction, ICU polyneuropathy, post-traumatic stress, malnutrition, etc.). Despite prolonged periods of rehabilitation, there is a significant decrease in functional status and quality of life compared to the previous status of these patient.

A specific management by a multidisciplinary team has been set up since 2017 at the Geneva-ICU for long-stay patients (hospitalised ≥ 7 days) including special attention to weaning from ventilation, nutrition, mobilisation, anxiety, pain, skin condition etc.

The culture of nutritional therapy and early mobilisation is already well established at the Geneva-ICU. However, a comprehensive approach to nutrition and mobilisation during and after the ICU stay could be optimised.

The objective of the study is to determine whether optimization of nutritional therapy combined with early mobilization for patients with long ICU stay will improve muscle function at discharge compared with patients receiving standard care.

Study Type

Interventional

Enrollment (Estimated)

164

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Any patient admitted to the adult ICU :

  • ≥18 years old
  • On mechanical ventilation with an expected length of stay ≥ 7 days
  • Requiring artificial nutrition (enteral and/or parenteral nutrition)

Exclusion Criteria:

Therapeutic withdrawal Pregnant or breastfeeding patients

Neurological disorders with motor deficits:

  • New or pre-existing neuromuscular or nervous system disease
  • Spinal cord injury Severe polytrauma of the lower limbs (amputation etc.) Non-independent ambulation (including walking aids) before ICU admission

For organizational reasons not allowing follow-up :

  • Transfer to another ICU
  • Patient living abroad from Switzerland
  • Patient living in nursing homes preceding to ICU admission
  • Incarcerated patients
  • Intellectual/cognitive disabilities or language barrier, limiting ability to follow the instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
Patients will receive nutritional therapy and mobilisation according to local standard procedures.
Experimental: Interventional group

Optimisation of nutrition therapy coupled with early mobilisation with:

  • Optimisation of nutrition therapy during ICU stay
  • Optimisation of physiotherapy during ICU stay
  • Better communication and closer collaboration between physiotherapy and nutrition teams.
  • Optimisation of continuity of the care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking distance
Time Frame: Hospital discharge or end of the intervention (4 weeks after ICU discharge)
6 MWT
Hospital discharge or end of the intervention (4 weeks after ICU discharge)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking distance
Time Frame: At ICU discharge (if achievable); 6 months post-ICU stay
6 MWT
At ICU discharge (if achievable); 6 months post-ICU stay
Body composition
Time Frame: At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Electrical bio impedance
At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Body composition
Time Frame: Within the 1st 48 hours post ICU admission, at ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Peripheral muscle ultrasound
Within the 1st 48 hours post ICU admission, at ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Grip Strength
Time Frame: At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Handgrip
At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Gradation of muscle function
Time Frame: At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
MRC
At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Physical functionality
Time Frame: At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
PFIT & SPPB
At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Weight difference
Time Frame: At ICU admission, at ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Comparison between weight at ICU admission, at hospital discharge and at 6 months post-ICU stay
At ICU admission, at ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Appetite
Time Frame: At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
10-point survey scale
At ICU discharge; at hospital discharge or end of the intervention; at 6 months post-ICU stay
Food intake estimation
Time Frame: At 6 months post-ICU stay
3 days food diary
At 6 months post-ICU stay
Quality of life (SF-12)
Time Frame: At 6 months post-ICU stay
SF-12
At 6 months post-ICU stay
Return to work/activity preceding to the event
Time Frame: At 6 months post-ICU stay
Collected during the 6 month post-ICU stay consultation
At 6 months post-ICU stay
Length of ICU and hospital stay
Time Frame: At ICU and hospital discharge
Collected in the patient form
At ICU and hospital discharge
Duration of mechanical ventilation
Time Frame: At ICU discharge
Collected in the patient form
At ICU discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Claudia Heidegger, MD, University Hospital, Geneva

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

March 23, 2023

First Submitted That Met QC Criteria

May 9, 2023

First Posted (Actual)

May 18, 2023

Study Record Updates

Last Update Posted (Actual)

August 12, 2025

Last Update Submitted That Met QC Criteria

August 7, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe